Viewing Study NCT01908335


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2025-12-25 @ 7:48 PM
Study NCT ID: NCT01908335
Status: COMPLETED
Last Update Posted: 2014-10-20
First Post: 2013-07-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C
Sponsor: Beijing Kawin Technology Share-Holding Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module